ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half | Fierce Biotech
2021 Novartis Multicultural Teen Corporate Mentoring Program Selects 26 Students from Hanover Park | East Hanover/Florham Park, NJ News TAPinto
Novartis taps growing Biofourmis for digital heart failure project | Fierce Biotech
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
Plasma neurodegeneration biomarker concentrations associate with glymphatic and meningeal lymphatic measures in neurological disorders | Nature Communications
Novartis to pay $370 million to settle claims it paid kickbacks for drug referrals | Healthcare Finance News
B2 novartis | PDF
Q&A: Is it a migraine? Many don't realize what causes their suffering | The Seattle Times
Lilly-Incyte drug reduces eczema symptoms in treatment-resistant patients | S&P Global Market Intelligence
Anumana partners with Novartis to develop AI cardiovascular disease detection tools | MobiHealthNews
Inclisiran Reduced LDL-C in Obese Patients | DAIC
Why Novartis Is Buying The Medicines Company For $9.7 Billion
AI and 10 seconds of voice can screen for diabetes, new Mayo Clinic journal study reveals - PharmaLive
Novartis, Sandoz recall 12 medications over packaging concerns | Fox 8 Cleveland WJW
Fundación Signo on X: "https://t.co/2eMh5pMGvt" / X